Landec Corporation (LNDC)


-0.32 (-3.52%)
Symbol LNDC
Price $8.76
Beta 1.102
Volume Avg. 0.06M
Market Cap 263.627M
Shares () -
52 Week Range 7.65-12.0389
1y Target Est -
DCF Unlevered LNDC DCF ->
DCF Levered LNDC LDCF ->
ROE -79.20% Strong Sell
ROA -35.00% Strong Sell
Operating Margin -
Debt / Equity 194.95% Buy
P/E -4.04 Strong Sell
P/B 2.67 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest LNDC news

Dr. Albert Bolles
Drug Manufacturers—Specialty & Generic
NASDAQ Global Select

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.